Skip to main content

Table 7 Mean values of EORTC QLQ C30 functional scales of breast cancer and colorectal cancer

From: Reliability and validity of a new scale on internal coherence (ICS) of cancer patients

STUDY 2 Quality of Life (EORTC)
  physical role emotional cognitive social Global
Breast cancer group 1 T0 78.75 (26.47) 66.67 (30.21) 54.17 (25.89) 85.42 (19.12) 67.78 (30.52) 60.42 (21.62)
Breast cancer group 1 T1 72.94 (23.27) 55.88 (30.01) 50.00 (21.73) 77.08 (22.27) 56.67 (33.21) 51.56 (22.20)
Breast cancer group 1 T2 76.86 (20.43) 64.71 (33.27) 46.08 (23.59) 68.63 (29.39) 57.84 (33.39) 58.33 (26.19)
Colorectal cancer T0 77.22 (23.42) 58.67 (38.53) 60.33 (26.60) 80.67 (19.65) 62.32 (28.07) 57.00 (22.91)
Colorectal cancer T1 69.07 (25.16) 60.00 (35.35) 63.19 (24.19) 71.33 (24.31) 67.33 (32.80) 54.71 (23.14)
Colorectal cancer T2 75.83 (19.67) 78.26 (27.26) 71.01 (25.85) 79.17 (19.19) 76.09 (25.04) 63.04 (25.48)
p-value T0 vs T1 ** 0.008 0.396 0.434 0.013 0.486 0.126
p-value T1 vs T2** 0.024 0.012 0.169 0.303 0.175 0.016
  1. ** Exact Wilcoxon-Test (1-side) used for pooled breast cancer and colorectal cancer and tests T0 (before chemotherapy) vs. T1 (1–5 days after third chemotherapy cycle) and T1 vs. T2 (4 – 8 weeks after the end of chemotherapy). Significant differences (p < 0.05) are presented bold.